Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece

NCT06185660 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06185660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06185660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 9, 2024
Completion date
January 3, 2025
Enrollment
125 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalaemia